Komori
Grcs (9250) · RiskDropped

Prolonged Spread of COVID-19

First written in FY2021. 3 of 6 entries say "Restated". Latest entry: FY2025.

6entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q2 – FY20252022: 420222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1250 companies write about · 1262 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1276 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025DroppedAnnual report

    「During the fiscal year, the Japanese economy recovered gradually, supported by improvements in employment and income conditions and various government policies.」

    The discussion of the economic environment in this filing does not identify the prolonged COVID-19 pandemic as a risk factor.
  2. FY2022RestatedAnnual report

    「The Group believes that COVID-19 currently has no significant impact on the execution of its business. However, the impact on the business environment of concerns over the prolonged spread of the infection and further restrictions on corporate activities remains uncertain and may affect the Group's performance.」

    Although the Group states that there is currently no significant impact, it continues to identify the uncertain effects of a prolonged infection and restrictions on corporate activities as risks.
  3. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, the Japanese economy was affected by the renewed increase in COVID-19 cases, but economic activity continued to resume, corporate earnings showed signs of improvement, and the economy was expected to enter a recovery phase.」

    The disclosure describes the economic impact of the renewed increase in COVID-19 cases, while also noting the resumption of economic activity and the improving trend in corporate earnings. It also states that there have been no material changes in the infection's impact on accounting estimates.
  4. FY2022-Q2RestatedAnnual report

    「During the cumulative second quarter, the Japanese economy saw a gradual easing of the severe conditions caused by restrictions as COVID-19 vaccinations progressed steadily, and corporate earnings and other indicators showed signs of improvement.」

    The disclosure describes progress in vaccinations and an easing of economic conditions, while stating that there have been no material changes in the impact of COVID-19 on accounting estimates.
  5. FY2022-Q1WorsenedAnnual report

    「Although conditions became difficult again as the number of COVID-19 cases, which had been kept at a low level, increased, corporate earnings have shown signs of recovery. Looking ahead, the Japanese domestic economy is expected to enter a recovery phase, owing to the effects of various policies and the improving trend in overseas economies. However, attention must still be paid to downside risks to the economy resulting from the infection and volatility in the financial and capital markets.」

    The disclosure continues to describe a difficult economic environment resulting from the increase in COVID-19 cases and downside risks to the economy. It does not state that the Company's performance has actually been affected.
  6. FY2021First statedAnnual report

    「Although the Company experienced a slight decline in activity during the state of emergency, it believes that COVID-19 currently has no significant impact on the execution of its business. However, the impact on the business environment of concerns over the prolonged spread of the infection and further restrictions on corporate activities remains uncertain and may affect the Company's performance.」

    Although the Company states that there is currently no significant impact on business execution, it identifies the uncertain effects of a prolonged spread of the infection and restrictions on corporate activities as risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Grcs yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Prolonged Spread of COVID-19 | GRCS Inc. (9250) | Komori